Cellular uptake mechanisms and toxicity of quantum dots in dendritic cells

Nanomedicine

Volumn 6, Issue 5, 2011, Pages 777-791

  Zhang, Leshuai W ^a   Bäumer, Wolfgang ^b   Monteiro Riviere, Nancy A ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

cellular uptake; dendritic cells; endocytosis; LPS; nanoparticles; quantum dot nanoparticles; scavenger receptor

Indexed keywords

ALAMAR BLUE; APOTOX; B7 ANTIGEN; CADMIUM SELENIDE; CARBOXYLIC ACID; CD14 ANTIGEN; CD86 ANTIGEN; CLATHRIN; DYE; F ACTIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; PHOSPHOLIPASE C; QD655 COOH; QUANTUM DOT; SCAVENGER RECEPTOR; UNCLASSIFIED DRUG; ZINC SULFIDE;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL VACUOLE; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; DENDRITIC CELL; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TOXICITY TESTING; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTIGENS, CD80; ANTIGENS, CD86; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; DENDRITIC CELLS; ENDOCYTOSIS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; LIPOPOLYSACCHARIDES; MONOCYTES; QUANTUM DOTS; SWINE;

EID: 79960951687     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.73     Document Type: Article

References (49)

1. Monteiro-Riviere NA, Nemanich RJ, Inman AO et al. Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol. Lett. 155, 377-384 (2005). (Pubitemid 40093001)
2. Monteiro-Riviere NA, Inman AO. Challenges for assessing carbon nanomaterial toxicity to the skin. Carbon 44, 1070-1078 (2006). (Pubitemid 43202164)
3. Rouse JG, Yang J, Barron AR et al. Fullerene-based amino acid nanoparticle interactions with human epidermal keratinocytes. Toxicol. In vitro. 20, 1313-1320 (2006). (Pubitemid 44537654)
4. Zhang LW, Yang J, Barron AR et al. Endocytic mechanisms and toxicity of a functionalized fullerene in human cells. Toxicol. Lett. 191, 149-157 (2009).
5. Zhang LW, Zeng L, Barron AR. Biological interactions of functionalized single-wall carbon nanotubes in human epidermal keratinocytes. Int. J. Toxicol. 26, 103-113 (2007). (Pubitemid 46514921)
6. Chithrani BD, Ghazani AA, Chan WC. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6, 662-668 (2006).
7. Samberg ME, Oldenburg SJ, Monteiro-Riviere NA. Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environ. Health Perspect. 118, 407-413 (2010).
8. Monteiro-Riviere NA, Oldenburg SJ, Inman AO. Interactions of aluminum nanoparticles with human epidermal keratinocytes. J. Appl. Toxicol. 30, 276-285 (2010).
9. Duan H, Nie S. Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings. J. Am. Chem. Soc. 129, 3333-3338 (2007).
10. Jaiswal JK, Mattoussi H, Mauro JM et al. Longterm multiple color imaging of live cells using quantum dot bioconjugates. Nat. Biotechnol. 21, 47-51 (2003). (Pubitemid 36055826)
11. Zhang LW, Yu WW, Colvin VL et al. Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. Toxicol. Appl. Pharmacol. 228, 200-211 (2008).
12. Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol. Sci. 91, 159-65 (2006).
13. Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. Surface coatings determine cytotoxicity and irritation potential of quantum dot nanoparticles in epidermal keratinocytes. J. Invest. Dermatol. 127, 143-153 (2007). (Pubitemid 46005672)
14. Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. Variables influencing interactions of untargeted quantum dot nanoparticles with skin cells and identification of biochemical modulators. Nano Lett. 7, 1344-1348 (2007). (Pubitemid 46834420)
15. Zhang LW, Monteiro-Riviere NA. Mechanisms of quantum dot nanoparticle cellular uptake. Toxicol. Sci. 110, 138-155 (2009).
16. Sallusto F, Cella M, Danieli C et al. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389-400 (1995).
17. Geissmann F, Prost C, Monnet JP et al. Transforming growth factor b1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J. Exp. Med. 187, 961-966 (1998). (Pubitemid 28141669)
18. Agger R, Petersen MS, Toldbod HE et al. Characterization of murine dendritic cells derived from adherent blood mononuclear cells in vitro. Scand. J. Immunol. 52, 138-147 (2000).
19. Howard CJ, Brooke GP, Werling D et al. Dendritic cells in cattle: phenotype and function. Vet. Immunol. Immunopathol. 72, 119-124 (1999).
20. Cambi A, Lidke DS, Arndt-Jovin DJ et al. Ligand-conjugated quantum dots monitor antigen uptake and processing by dendritic cells. Nano Lett. 7, 970-977 (2007). (Pubitemid 46717743)
21. Elamanchili P, Diwan M, Cao M et al. Characterization of poly (d,l-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells. Vaccine 22, 2406-2412 (2004). (Pubitemid 38757337)
22. Manolova V, Flace A, Bauer M et al. Nanoparticles target distinct dendritic cell populations according to their size. Eur. J. Immunol. 38, 1404-1413 (2008).
23. Coester C, Nayyar P, Samuel J. In vitro uptake of gelatin nanoparticles by murine dendritic cells and their intracellular localisation. Eur. J. Pharm. Biopharm. 62, 306-314 (2006). (Pubitemid 43356580)
24. Nabiev I, Mitchell S, Davies A et al. Nonfunctionalized nanocrystals can exploit a cell's active transport machinery delivering them to specific nuclear and cytoplasmic compartments. Nano Lett. 7, 3452-3461 (2007). (Pubitemid 350216045)
25. Hochrein H, Wagner H. Of men, mice and pigs: looking at their plasmacytoid dendritic cells. Immunology 112, 26-27 (2004). (Pubitemid 38609818)
26. Carrasco CP, Rigden RC, Schaffner R et al. Porcine dendritic cells generated in vitro: morphological, phenotypic and functional properties. Immunology 104, 175-184 (2001). (Pubitemid 32990043)
27. Raymond CR, Wilkie BN. Toll-like receptor, MHC II, B7 and cytokine expression by porcine monocytes and monocytederived dendritic cells in response to microbial pathogenassociated molecular patterns. Vet. Immunol. Immunopathol. 107, 235-247 (2005). (Pubitemid 40982032)
28. Summerfield A, McCullough KC. The porcine dendritic cell family. Dev. Comp. Immunol. 33, 299-309 (2009).
29. van Furth R, Cohn ZA, Hirsch JG et al. The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull World Health Organ. 46, 845-852 (1972).
30. Monteiro-Riviere NA, Inman AO, Zhang LW. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol. Appl. Pharmacol. 234, 222-235 (2009).
31. Paillot R, Laval F, Audonnet JC et al. Functional and phenotypic characterization of distinct porcine dendritic cells derived from peripheral blood monocytes. Immunology 102, 396-404 (2001). (Pubitemid 32322952)
32. van Weert AW, Dunn KW, Gueze HJ et al. Transport from late endosomes to lysosomes, but not sorting of integral membrane proteins in endosomes, depends on the vacuolar proton pump. J. Cell. Biol. 130, 21-24 (1995).
33. Yamada H, Arai T, Endo N et al. LPS-induced ROS generation and changes in glutathione level and their relation to the maturation of human monocyte-derived dendritic cells. Life Sci. 78, 926-933 (2005). (Pubitemid 43112529)
34. Hope JC, Cumberbatch M, Fielding I. Identification of dendritic cells as a major source of interleukin-6 in draining lymph nodes following skin sensitization of mice. Immunology 86, 441-447 (1995).
35. Reddy ST, Swartz MA, Hubbell JA. Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol. 27, 573-579 (2006). (Pubitemid 44708833)
36. Cruz LJ, Tacken PJ, Fokkink R et al. Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro. J. Control. Release. 144, 118-126 (2010).
37. Uto T, Wang X, Sato K et al. Targeting of antigen to dendritic cells with poly(g-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity. J. Immunol. 178, 2979-2986 (2007). (Pubitemid 46333177)
38. Leroux JC, De Jaeghere F, Anner B et al. An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(d,l-lactic acid) nanoparticles by human monocytes. Life Sci. 57, 695-703 (1995).
39. Garrett WS, Chen LM, Kroschewski R et al. Developmental control of endocytosis in dendritic cells by Cdc42. Cell 102, 325-34 (2000).
40. Merrifield CJ, Feldman ME, Wan L et al. Imaging actin and dynamin recruitment during invagination of single clathrin-coated pits. Nat. Cell Biol. 4, 691-698 (2002). (Pubitemid 34993705)
41. Kruth HS, Jones NL, Huang W et al. Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native low density lipoprotein. J. Biol. Chem. 280, 2352-2360 (2005).
42. Katoh K, Kano Y, Amano M et al. Rho-kinase-mediated contraction of isolated stress fibers. J. Cell Biol. 153, 569-584 (2001).
43. Makranz C, Cohen G, Baron A et al. Phosphatidylinositol 3-kinase, phosphoinositide-specific phospholipase-Cg and protein kinase-C signal myelin phagocytosis mediated by complement receptor-3 alone and combined with scavenger receptor-AI/II in macrophages. Neurobiol. Dis. 15, 279-286 (2004). (Pubitemid 38296759)
44. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor a. J. Exp. Med. 179, 1109-1118 (1994).
45. Platt CD, Ma JK, Chalouni C. Mature dendritic cells use endocytic receptors to capture and present antigens. Proc. Natl. Acad. Sci. USA 107, 4287-4292 (2010).
46. Barth H, Schnober EK, Neumann-Haefelin C et al. Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells. J. Virol. 82, 3466-3479 (2008). (Pubitemid 351429922)
47. Taront S, Dieudonn A, Blanchard S et al. Implication of scavenger receptors in the interactions between diesel exhaust particles and immature or mature dendritic cells. Part. Fibre. Toxicol. 13, 6-9 (2009).
48. Nickel T, Schmauss D, Hanssen H et al. oxLDL uptake by dendritic cells induces upregulation of scavenger-receptors, maturation and differentiation. Atherosclerosis 205, 442-450 (2009).
49. Kwon YJ, James E, Shastri N et al. In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles. Proc. Natl Acad. Sci. USA 102, 18264-18268 (2005). (Pubitemid 43011215)